CP1
Click for more information
0.00% 17.0¢ cannpal animal therapeutics limited

CP1 Re-rate coming?, page-6

  1. Buzz83
    29 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    08/03/19
    07:50
    Post #: 37693263
    I have always thought that this will end in a take over

    My guesses were big pharma, however I didn't anticipate just how cashed up and powerful international marijuana companies are becoming.

    I would like to think that this little Australian company development of CPAT-1 is more advanced than its counter parts.
    CP1 Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.